Browsing Tag

Hypercholesterolemia

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002…

Eli Pacheco Jan 10, 2023 0

LA JOLLA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock…

Health

Seven Factors Account for 85% of Acute MI Risk in Young Americans

Eli Pacheco May 4, 2022 0

Seven risk factors, some modifiable and some not, accounted for the vast majority of risk for…

Health

MediciNova Receives a New Patent Covering MN-001 for the Treatment of…

Eli Pacheco Feb 1, 2022 0

LA JOLLA, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock…

Health

AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an…

Eli Pacheco Dec 22, 2021 0

Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential…

Health

New Algorithm Predicts Familial Hypercholesterolemia

Eli Pacheco Jun 9, 2021 0

is a condition in which low-density lipoprotein (LDL) levels elevate in the blood. The complications related to this disorder include atherosclerosis and heart disease at an early age. It…